SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Solvay S.A. (SVYSF) trades at a trailing P/E of 117.2, forward P/E of 12.5. Trailing earnings yield is 0.85%, forward earnings yield 8.00%. PEG 0.01 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (15/100, Fail) — trailing P/E is well above the S&P 500 average of ~25, suggesting a premium valuation (P/E 117.2); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY 0.85%).
- Forward P/E 12.5 (down from trailing 117.2) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.01 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 0.85% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 8.00% as earnings recover.
Overall SharesGrow Score: 38/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
15/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — SVYSF
Valuation Multiples
P/E (TTM)117.2
Forward P/E12.5
PEG Ratio0.01
Forward PEG0.01
P/B Ratio0.00
P/S Ratio0.73
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.28
Forward EPS (Est.)$2.62
Book Value / Share$0.00
Revenue / Share$44.97
FCF / Share$0.00
Yields & Fair Value
Earnings Yield0.85%
Forward Earnings Yield8.00%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$5.99 |
$10.05B |
$621M |
6.2% |
| 2017 |
$10.19 |
$10.98B |
$1.06B |
9.7% |
| 2018 |
$8.45 |
$11.3B |
$877M |
7.8% |
| 2019 |
$1.14 |
$11.23B |
$118M |
1.1% |
| 2020 |
$-9.33 |
$9.71B |
$-962M |
-9.9% |
| 2021 |
$9.13 |
$11.44B |
$948M |
8.3% |
| 2022 |
$18.29 |
$16.07B |
$1.91B |
11.9% |
| 2023 |
$20.09 |
$6.03B |
$2.09B |
34.7% |
| 2024 |
$2.12 |
$5.13B |
$223M |
4.3% |
| 2025 |
$0.28 |
$4.74B |
$29.99M |
0.6% |